Relay Therapeutics RLAY 深 沪
等待开盘 12-16 09:30:00 美东时间
8.48
+0.450
+5.60%
华盛通- 最 高8.53
- 今 开8.08
- 成交量 245.12万股
- 最 低 8.005
- 昨 收 8.03
- 总市值 14.67亿
- 52周最高 8.70
- 市盈率 静 --
- 换手率 1.42%
- 52周最低 1.775
- 委 比 -67.93%
- 总股本 1.73亿
- 历史最高 64.37
- 量 比 0.91
- 振 幅 6.54%
- 历史最低 1.775
- 每 手 1
- 风险率 1.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
Relay Therapeutics Presents Subset Analysis Of Interim Phase 3 Data For Zovegalisib At SABCS 2025
Efficacy data remain consistent with previous disclosures, showing 10.3-month median PFS in all patients and 11.4-month median PFS in 2L patientsSubset analyses show broad activity in patients with PI3Kα-mutated,
12-12 20:05
Positive Report for Relay Therapeutics (RLAY) from Wells Fargo
Relay Therapeutics received a Buy rating and a price target from Wells Fargo an...
12-12 18:35
美股牛股 | OSCR大涨超22%，白宫计划延长奥巴马医改补贴；加密财库公司BitMine大涨19.6%
OSCR大涨超22%，白宫计划延长奥巴马医改补贴；加密财库公司BitMine大涨19.6%，持有3%的ETH代币供应量>>
11-25 15:10
Alibaba, Oscar Health, Ondas Holdings, Lumentum, Tesla And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones gaining around 250 points on Monday...
11-25 00:06
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
Wells Fargo Maintains Equal-Weight on Relay Therapeutics, Raises Price Target to $6
Wells Fargo analyst Eva Fortea Verdejo maintains Relay Therapeutics (NASDAQ:RLAY) with a Equal-Weight and raises the price target from $4 to $6.
11-08 02:54
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
<p>Relay Therapeutics (Nasdaq: RLAY), a clinical-stage precision medicine company, announces it will release its third quarter 2025 financial results and corporate updates after market close on Thursday, November 6, 2025. The company is focused on developing life-changing therapies for patients with cancer and genetic diseases using its Dynamo® platform, which integrates computational and experimental technologies to target previously challenging...
10-30 20:05
